Literature DB >> 9123119

Tacrolimus (FK506) is superior to cyclosporine in liver transplantation.

R W Busuttil1, C D Holt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9123119     DOI: 10.1016/s0041-1345(96)00630-6

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  7 in total

Review 1.  [Systemic immunosuppressives after penetrating keratoplasty].

Authors:  A Reis; F Birnbaum; T Reinhard
Journal:  Ophthalmologe       Date:  2007-05       Impact factor: 1.059

Review 2.  Ethics in clinical research: searching for absolutes.

Authors:  K S Joseph
Journal:  CMAJ       Date:  1998-05-19       Impact factor: 8.262

3.  Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.

Authors:  G L Plosker; R H Foster
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

Review 4.  Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation.

Authors:  C M Spencer; K L Goa; J C Gillis
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

5.  Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506).

Authors:  Biagio De Angelis; Gianpietro Dotti; Concetta Quintarelli; Leslie E Huye; Lan Zhang; Ming Zhang; Fabrizio Pane; Helen E Heslop; Malcolm K Brenner; Cliona M Rooney; Barbara Savoldo
Journal:  Blood       Date:  2009-09-16       Impact factor: 22.113

6.  Immunosuppression strategies after liver transplantation: a single centre experience in 57 liver transplant recipients.

Authors:  Rajeev Sharma; M R Rajasekar; Arun Raghuvanshi
Journal:  Indian J Surg       Date:  2008-07-30       Impact factor: 0.656

7.  Tacrolimus-Associated Dilated Cardiomyopathy in Adult Patient After Orthotopic Liver Transplant.

Authors:  Jennifer McLeod; Stephanie Wu; Luanda Grazette; Anna Sarcon
Journal:  J Investig Med High Impact Case Rep       Date:  2017-04-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.